Inventiva (IVA) Projected to Post Earnings on Wednesday

Inventiva (NASDAQ:IVA) is expected to be posting its quarterly earnings results before the market opens on Wednesday, March 26th. Analysts expect Inventiva to post earnings of ($0.43) per share for the quarter. Persons that wish to register for the company’s earnings conference call can do so using this link.

Inventiva Price Performance

Shares of NASDAQ IVA opened at $2.88 on Monday. Inventiva has a 1 year low of $1.53 and a 1 year high of $3.98. The firm has a 50-day moving average of $2.63 and a 200 day moving average of $2.46.

Analyst Ratings Changes

Several equities analysts have recently issued reports on the stock. HC Wainwright reiterated a “buy” rating and set a $13.00 target price on shares of Inventiva in a report on Thursday, January 30th. TD Cowen started coverage on Inventiva in a research note on Friday, February 21st. They set a “buy” rating and a $10.00 price objective for the company. One research analyst has rated the stock with a hold rating and four have given a buy rating to the company. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $12.60.

About Inventiva

Inventiva SA, a clinical-stage biopharmaceutical company, focuses on the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis (NASH) and other diseases. Its lead product candidate is Lanifibranor, which is in Phase III clinical trial to treat NASH. The company also develops Odiparcil for the treatment of patients with mucopolysaccharidoses type VI.